England’s National Institute for Health and Care Excellence (NICE) has given a second thumbs down to a pair of Alzheimer’s ...
Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both ...
Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both slowed the progression of the memory-robbing illness.
As a consultant physician at UCL Hospitals, I have seen many young people turning up on the wards following a heart attack or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results